We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients (IoN)

This study is currently recruiting participants.
Verified October 2016 by University College, London
Sponsor:
ClinicalTrials.gov Identifier:
NCT01398085
First Posted: July 20, 2011
Last Update Posted: October 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Cancer Research UK
Information provided by (Responsible Party):
University College, London
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2021
  Estimated Primary Completion Date: November 2020 (Final data collection date for primary outcome measure)